Zhou Yaofeng, Fan Siyu, Feng Lili, Huang Xiaolin, Chen Xiaoyuan
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Nanchang University, Nanchang, 330047, P. R. China.
School of Qianhu, Nanchang University, Nanchang, 330047, P. R. China.
Adv Mater. 2021 Dec;33(48):e2104223. doi: 10.1002/adma.202104223. Epub 2021 Sep 27.
Chemodynamic therapy (CDT) uses the tumor microenvironment-assisted intratumoral Fenton reaction for generating highly toxic hydroxyl free radicals (•OH) to achieve selective tumor treatment. However, the limited intratumoral Fenton reaction efficiency restricts the therapeutic efficacy of CDT. Recent years have witnessed the impressive development of various strategies to increase the efficiency of intratumoral Fenton reaction. The introduction of these reinforcement strategies can dramatically improve the treatment efficiency of CDT and further promote the development of enhanced CDT (ECDT)-based multimodal anticancer treatments. In this review, the authors systematically introduce these reinforcement strategies, from their basic working principles, reinforcement mechanisms to their representative clinical applications. Then, ECDT-based multimodal anticancer therapy is discussed, including how to integrate these emerging Fenton reinforcement strategies for accelerating the development of multimodal anticancer therapy, as well as the synergistic mechanisms of ECDT and other treatment methods. Eventually, future direction and challenges of ECDT and ECDT-based multimodal synergistic therapies are elaborated, highlighting the key scientific problems and unsolved technical bottlenecks to facilitate clinical translation.
化学动力学疗法(CDT)利用肿瘤微环境辅助的肿瘤内芬顿反应生成高毒性的羟基自由基(•OH),以实现选择性肿瘤治疗。然而,肿瘤内芬顿反应效率有限,限制了CDT的治疗效果。近年来,各种提高肿瘤内芬顿反应效率的策略取得了显著进展。这些强化策略的引入可以显著提高CDT的治疗效率,并进一步推动基于增强化学动力学疗法(ECDT)的多模态抗癌治疗的发展。在这篇综述中,作者系统地介绍了这些强化策略,从其基本工作原理、强化机制到其代表性临床应用。然后,讨论了基于ECDT的多模态抗癌治疗,包括如何整合这些新兴的芬顿强化策略以加速多模态抗癌治疗的发展,以及ECDT与其他治疗方法的协同机制。最后,阐述了ECDT和基于ECDT的多模态协同治疗的未来方向和挑战,突出了关键科学问题和未解决的技术瓶颈,以促进临床转化。
Nanomedicine (Lond). 2022-10
Adv Healthc Mater. 2024-4
ACS Appl Mater Interfaces. 2019-6-19
Angew Chem Int Ed Engl. 2018-11-20
Adv Healthc Mater. 2024-9
ACS Appl Mater Interfaces. 2021-8-11
Nat Commun. 2025-8-28
Int J Nanomedicine. 2025-7-3
Adv Healthc Mater. 2025-8